Andrew Schwartz
About Andrew Schwartz
Andrew Schwartz is a Scientist I in Analytical Development at Bristol-Myers Squibb and Celgene, with a background in both philosophy and chemistry.
Title
Andrew Schwartz holds the position of Scientist I, Analytical Development at both Bristol-Myers Squibb in New Jersey and Celgene in Summit, New Jersey.
Company
Andrew Schwartz is currently working at Bristol-Myers Squibb, a global biopharmaceutical company, and Celgene, which specializes in the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases.
Education and Expertise
Andrew Schwartz earned a Doctor of Philosophy degree in Philosophy and Chemistry from Indiana University Bloomington, studying from 2010 to 2016. He also holds a Bachelor of Science degree in Chemistry from Huntington University, which he completed between 2006 and 2010. His educational background combines interdisciplinary knowledge in philosophy and chemistry, providing a solid foundation for his research.
Background
Andrew Schwartz has a diversified background with experience in both academic and industrial research settings. He previously worked as a Postdoctoral Research Scholar at the University at Buffalo from 2016 to 2018, and as a Research Associate and Associate Instructor at Indiana University from 2010 to 2016. Additionally, he has experience as a Research Collaborator and Laboratory Assistant at Huntington University.
Achievements
Andrew Schwartz has contributed to various analytical development projects at leading biopharmaceutical companies such as Bristol-Myers Squibb and Celgene. He has also gained practical experience in NMR instrumentation during a practicum at Huntington University and actively contributed to research projects both as a collaborator and laboratory assistant.